Meta-Analysis
Copyright ©The Author(s) 2022.
World J Gastrointest Oncol. Oct 15, 2022; 14(10): 2061-2076
Published online Oct 15, 2022. doi: 10.4251/wjgo.v14.i10.2061
Figure 3
Figure 3 Forest plots on the assessment of progression-free survival in biliary tract cancer patients treated with chemotherapy + targeted therapy or chemotherapy alone. A: Overall population; B: Subgroup analysis according to agent targets; C: Subgroup analysis according to chemotherapy regimens. EGFR: Epidermal growth factor receptor; VEGFR: Vascular endothelial growth factor receptor; MET: Mesenchymal-epithelial transition factor.